Titre : Hawaïen autochtone ou autre insulaire du Pacifique

Hawaïen autochtone ou autre insulaire du Pacifique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Prostatitis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hawaïen autochtone ou autre insulaire du Pacifique : Questions médicales les plus fréquentes", "headline": "Hawaïen autochtone ou autre insulaire du Pacifique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hawaïen autochtone ou autre insulaire du Pacifique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-09", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hawaïen autochtone ou autre insulaire du Pacifique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Population originaire des îles du Pacifique", "url": "https://questionsmedicales.fr/mesh/D000095188", "about": { "@type": "MedicalCondition", "name": "Population originaire des îles du Pacifique", "code": { "@type": "MedicalCode", "code": "D000095188", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01.686.493.500.800" } } }, "about": { "@type": "MedicalCondition", "name": "Hawaïen autochtone ou autre insulaire du Pacifique", "alternateName": "Native Hawaiian or Other Pacific Islander", "code": { "@type": "MedicalCode", "code": "D044468", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Pearl A McElfish", "url": "https://questionsmedicales.fr/author/Pearl%20A%20McElfish", "affiliation": { "@type": "Organization", "name": "College of Medicine, University of Arkansas for Medical Sciences Northwest, 2708 S. 48th St, Springdale, AR, 72762, USA. pamcelfish@uams.edu." } }, { "@type": "Person", "name": "Marie-Rachelle Narcisse", "url": "https://questionsmedicales.fr/author/Marie-Rachelle%20Narcisse", "affiliation": { "@type": "Organization", "name": "Office of Community Health and Research, University of Arkansas for Medical Sciences, 1125 N. College Ave, Fayetteville, AR 72703, USA." } }, { "@type": "Person", "name": "Joseph Keawe'aimoku Kaholokula", "url": "https://questionsmedicales.fr/author/Joseph%20Keawe%27aimoku%20Kaholokula", "affiliation": { "@type": "Organization", "name": "Department of Native Hawaiian Health, John A. Burns School of Medicine, University of Hawai'i at Manoa, 651 Ilalo St, Honolulu, HI, 96813, USA." } }, { "@type": "Person", "name": "Eunjung Lim", "url": "https://questionsmedicales.fr/author/Eunjung%20Lim", "affiliation": { "@type": "Organization", "name": "Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawai'i at Manoa, Honolulu, HI (JD, EL, JC)." } }, { "@type": "Person", "name": "Brett Rowland", "url": "https://questionsmedicales.fr/author/Brett%20Rowland", "affiliation": { "@type": "Organization", "name": "Office of Community Health and Research, University of Arkansas for Medical Sciences Northwest, 2708 S. 48th St, Springdale, AR, 72762, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Post-prostatic-massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate-cancer-typical microRNAs and activate proto-oncogenes.", "datePublished": "2022-11-17", "url": "https://questionsmedicales.fr/article/36321189", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/1878-0261.13329" } }, { "@type": "ScholarlyArticle", "name": "Effects of low-intensity pulsed ultrasound on the microorganisms of expressed prostatic secretion in patients with IIIB prostatitis.", "datePublished": "2024-07-04", "url": "https://questionsmedicales.fr/article/38965410", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-66329-x" } }, { "@type": "ScholarlyArticle", "name": "Preclinical models and evaluation criteria of prostatitis.", "datePublished": "2023-05-09", "url": "https://questionsmedicales.fr/article/37228599", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2023.1183895" } }, { "@type": "ScholarlyArticle", "name": "Chronic prostatitis as possible risk factor for Peyronie's disease: Psychological, sexual and prostatitis-like symptoms in patients with PD.", "datePublished": "2023-05-31", "url": "https://questionsmedicales.fr/article/37259816", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4081/aiua.2023.11406" } }, { "@type": "ScholarlyArticle", "name": "How I manage bacterial prostatitis.", "datePublished": "2022-06-13", "url": "https://questionsmedicales.fr/article/35709903", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cmi.2022.05.035" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Populations d'Océanie", "item": "https://questionsmedicales.fr/mesh/D000094862" }, { "@type": "ListItem", "position": 4, "name": "Populations d'Australasie", "item": "https://questionsmedicales.fr/mesh/D000094861" }, { "@type": "ListItem", "position": 5, "name": "Population originaire des îles du Pacifique", "item": "https://questionsmedicales.fr/mesh/D000095188" }, { "@type": "ListItem", "position": 6, "name": "Hawaïen autochtone ou autre insulaire du Pacifique", "item": "https://questionsmedicales.fr/mesh/D044468" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hawaïen autochtone ou autre insulaire du Pacifique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hawaïen autochtone ou autre insulaire du Pacifique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hawaïen autochtone ou autre insulaire du Pacifique", "description": "Comment diagnostiquer une maladie chez les Hawaïens autochtones ?\nQuels tests sont recommandés pour les insulaires du Pacifique ?\nY a-t-il des particularités dans le diagnostic ?\nComment évaluer les risques de maladies spécifiques ?\nLes maladies génétiques sont-elles plus fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Prostatitis&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hawaïen autochtone ou autre insulaire du Pacifique", "description": "Quels symptômes sont courants chez les Hawaïens autochtones ?\nComment les symptômes diffèrent-ils selon les îles ?\nY a-t-il des symptômes spécifiques aux maladies tropicales ?\nLes symptômes psychologiques sont-ils fréquents ?\nComment les symptômes sont-ils perçus culturellement ?", "url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Prostatitis&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hawaïen autochtone ou autre insulaire du Pacifique", "description": "Quelles sont les stratégies de prévention pour ces populations ?\nComment promouvoir un mode de vie sain ?\nY a-t-il des campagnes de vaccination spécifiques ?\nComment réduire les risques de maladies chroniques ?\nQuel rôle joue l'éducation communautaire ?", "url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Prostatitis&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hawaïen autochtone ou autre insulaire du Pacifique", "description": "Quels traitements sont adaptés aux Hawaïens autochtones ?\nY a-t-il des remèdes traditionnels utilisés ?\nComment intégrer la médecine moderne et traditionnelle ?\nQuels médicaments sont couramment prescrits ?\nComment les traitements varient-ils selon l'île ?", "url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Prostatitis&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hawaïen autochtone ou autre insulaire du Pacifique", "description": "Quelles complications sont fréquentes chez ces populations ?\nComment les complications sont-elles gérées ?\nY a-t-il des complications spécifiques aux maladies tropicales ?\nComment prévenir les complications liées au diabète ?\nLes complications psychologiques sont-elles courantes ?", "url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Prostatitis&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hawaïen autochtone ou autre insulaire du Pacifique", "description": "Quels sont les principaux facteurs de risque ?\nComment l'environnement influence-t-il la santé ?\nY a-t-il des facteurs génétiques à considérer ?\nQuel impact a le mode de vie sur la santé ?\nComment les inégalités sociales affectent-elles la santé ?", "url": "https://questionsmedicales.fr/mesh/D044468?mesh_terms=Prostatitis&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une maladie chez les Hawaïens autochtones ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique médical, les symptômes et des tests spécifiques." } }, { "@type": "Question", "name": "Quels tests sont recommandés pour les insulaires du Pacifique ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins, d'imagerie et des évaluations génétiques peuvent être nécessaires." } }, { "@type": "Question", "name": "Y a-t-il des particularités dans le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs culturels et environnementaux peuvent influencer le diagnostic." } }, { "@type": "Question", "name": "Comment évaluer les risques de maladies spécifiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation des antécédents familiaux et des facteurs environnementaux est cruciale." } }, { "@type": "Question", "name": "Les maladies génétiques sont-elles plus fréquentes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies génétiques peuvent être plus fréquentes dans ces populations." } }, { "@type": "Question", "name": "Quels symptômes sont courants chez les Hawaïens autochtones ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, mais incluent souvent des problèmes respiratoires et métaboliques." } }, { "@type": "Question", "name": "Comment les symptômes diffèrent-ils selon les îles ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent varier en fonction des différences environnementales et génétiques." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux maladies tropicales ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la fièvre, les éruptions cutanées et la fatigue sont fréquents." } }, { "@type": "Question", "name": "Les symptômes psychologiques sont-ils fréquents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes de stress et d'anxiété peuvent être plus présents dans ces populations." } }, { "@type": "Question", "name": "Comment les symptômes sont-ils perçus culturellement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La perception des symptômes peut être influencée par des croyances culturelles et traditionnelles." } }, { "@type": "Question", "name": "Quelles sont les stratégies de prévention pour ces populations ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des programmes de sensibilisation et d'éducation sur la santé sont essentiels." } }, { "@type": "Question", "name": "Comment promouvoir un mode de vie sain ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Encourager l'activité physique, une alimentation équilibrée et des examens réguliers." } }, { "@type": "Question", "name": "Y a-t-il des campagnes de vaccination spécifiques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des campagnes ciblées pour des maladies comme l'hépatite B sont mises en place." } }, { "@type": "Question", "name": "Comment réduire les risques de maladies chroniques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Promouvoir des dépistages réguliers et des interventions précoces est crucial." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation communautaire ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation communautaire aide à sensibiliser et à mobiliser les ressources locales." } }, { "@type": "Question", "name": "Quels traitements sont adaptés aux Hawaïens autochtones ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements doivent être personnalisés, tenant compte des spécificités culturelles et médicales." } }, { "@type": "Question", "name": "Y a-t-il des remèdes traditionnels utilisés ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des remèdes à base de plantes et des pratiques traditionnelles sont souvent utilisés." } }, { "@type": "Question", "name": "Comment intégrer la médecine moderne et traditionnelle ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Une approche intégrative peut améliorer l'adhésion au traitement et le bien-être global." } }, { "@type": "Question", "name": "Quels médicaments sont couramment prescrits ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les médicaments pour les maladies chroniques comme le diabète et l'hypertension sont fréquents." } }, { "@type": "Question", "name": "Comment les traitements varient-ils selon l'île ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent varier en fonction de l'accès aux soins et des ressources disponibles." } }, { "@type": "Question", "name": "Quelles complications sont fréquentes chez ces populations ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des maladies cardiovasculaires et des troubles métaboliques." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique un suivi régulier et des ajustements de traitement appropriés." } }, { "@type": "Question", "name": "Y a-t-il des complications spécifiques aux maladies tropicales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications comme la dengue et le chikungunya peuvent survenir." } }, { "@type": "Question", "name": "Comment prévenir les complications liées au diabète ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Un contrôle glycémique rigoureux et des soins des pieds sont essentiels." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles courantes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications comme la dépression peuvent être fréquentes dans ces populations." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'obésité, le tabagisme et l'accès limité aux soins de santé." } }, { "@type": "Question", "name": "Comment l'environnement influence-t-il la santé ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs environnementaux comme la pollution et l'accès à l'eau potable jouent un rôle." } }, { "@type": "Question", "name": "Y a-t-il des facteurs génétiques à considérer ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des prédispositions génétiques à certaines maladies sont observées dans ces populations." } }, { "@type": "Question", "name": "Quel impact a le mode de vie sur la santé ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sédentaire et une mauvaise alimentation augmentent les risques de maladies." } }, { "@type": "Question", "name": "Comment les inégalités sociales affectent-elles la santé ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les inégalités d'accès aux soins et à l'éducation aggravent les problèmes de santé." } } ] } ] }

Sources (10000 au total)

Chronic prostatitis as possible risk factor for Peyronie's disease: Psychological, sexual and prostatitis-like symptoms in patients with PD.

This study aims to investigate a possible relationship between chronic prostatitis (CP) and Peyronie's disease (PD) and to characterize the psychological profile of patients suffering from PD, with or... We included 539 patients with PD, of which 200 were found to have underlying CP. As a comparator population, we selected 2201 patients without PD, referring to our tertiary care clinic. In this popula... The overall prevalence of chronic prostatitis in PD patients was 37.1% compared to a prevalence of 17.4% in the non-PD control population (OR = 2.79 and p < 0.0001). The severity of CP symptom total s... Chronic prostatitis (CP) and Peyronie's disease (PD) are frequently associated. Our results demonstrate the strong impact of chronic prostatitis on the mental status of PD patients. Anxiety and depres...

How I manage bacterial prostatitis.

Bacterial prostatitis is a highly prevalent infection responsible for significant morbidity among men. The diagnosis and treatment for bacterial prostatitis remains complicated. The difficulty in diag... We aimed to provide a useful resource for clinicians in effectively diagnosing and managing acute bacterial prostatitis (ABP) and chronic bacterial prostatitis (CBP).... A PubMed literature search on prostatitis was performed with no restrictions on publication date.... The epidemiology, pathophysiology, diagnosis, and treatment for ABP and CBP are explored using a clinical vignette as relevant context.... Bacterial prostatitis can be diagnosed through a focused history and microbiological investigations. The Meares-Stamey 4-glass test or modified 2-glass test can help confirm the diagnosis if uncertain...

Pharmacotherapeutic interventions for the treatment of bacterial prostatitis.

Bacterial prostatitis, acute or chronic, is one of the most prevalent urogenital infections in men. Its diagnosis requires the application of a careful methodology. Gram-negative bacilli are the most ... The aim of this article is to summarize the current evidence regarding the pathogenesis, etiology, empirical and definitive antimicrobial therapy, and new pharmacotherapeutic interventions to improve ... Bacterial prostatitis requires the application of an accurate diagnostic protocol to identify the causative agent and establish the optimal antimicrobial treatment. The structural and biochemical char...

Correlation of resistive index of prostatic capsular artery to clinical symptoms in men with chronic prostatitis/chronic pelvic pain syndrome.

To evaluate the relation between resistive index (RI) of prostatic capsular arteries by transrectal Doppler ultrasonography in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and its correl... In total, we included 68 patients presenting with chronic prostatitis/chronic pelvic pain syndrome. We formed two groups, as Group 1 of 35 patients with a RI ≥ 0.7 and Group 2 of 33 patients with RI <... Demographic characteristics were similar in the two groups. IPSS was 11.3 ± 6 in Group 1 and 9.7 ± 5.3 in Group 2. IIEF-5 was 18.6 ± 2 in Group 1 and 20.4 ± 2.3 in Group 2. PEDT was 12.4 ± 5.6 in Grou... There is a significant correlation between the lower urinary tract symptoms and erectile dysfunction parameters and the RI of the prostatic capsular artery in CP/CPPS and RI is an effective and noninv...

Does histological prostatic inflammation during transurethral resection of the prostate for bladder outlet obstruction affect post-operative urinary outcomes?

Benign prostate hyperplasia (BPH) is a common cause for bladder outlet obstruction (BOO) and lower urinary tract symptoms (LUTS) in men. The pathophysiology of BPH is multifactorial and inflammation h... Patients who had undergone TURP for BPH at a single institution between 2014 and 2018 were included. The study population was divided into three cohorts: those with no histological inflammation, those... A total 198 patients were included (no inflammation n = 101; any inflammation n = 97, prostatic stromal inflammation n = 81). All three groups were comparable in terms of baseline characteristics. The... Histological prostatitis is associated with worse urinary outcomes after TURP compared to no inflammation. These results are useful in improving prognostic discussions with patients after TURP....

Strong PD-L1 expression in granulomatous prostatitis.

The expression of programmed cell death ligand protein (PD-L1) is weakly investigated in non-tumoral and inflammatory prostatic pathology. The diagnosis of granulomatous prostatitis (GP) rests on the ... We studied PD-L1 expression in 17 GP cases (9 nonspecific GP, 5 Bacillus Calmette-Guérin induced prostatitis, 1 prostatic tuberculosis, and 3 cases of postsurgical prostatic granulomas). The control g... All of the GP cases showed easily visible strong membranous PD-L1 expression (high levels of combined positive score) in localized and diffuse epithelioid granulomatous prostatic inflammation. None of... The study presents the first attempt to examine PD-L1 expression in GP. Granulomatous inflammation in GP is easily identified when stained with PD-L1....